What specific benefits does Methenolone Enanthate in British Dragon Primobol 100 offer over other injectable androgens for body recomposition?

Methenolone Enanthate offers zero aromatase conversion, negligible progestogenic activity, and a low androgenic index (~44–57 on standardised assays), making it uniquely suited to simultaneous fat loss and muscle preservation. Unlike testosterone-based injectables, it contributes no aromatisable substrate, so oestradiol and subcutaneous fluid remain controlled throughout a caloric deficit, allowing lean-tissue gains to be accurately assessed.

Why do experienced bodybuilders specifically choose British Dragon Primobol 100 rather than a higher-concentration Methenolone product?

The 100mg/ml concentration delivers 50mg per 0.5ml, providing the finest weekly dose-adjustment resolution available in the injectable Methenolone range. Users running 200–400mg per week can step doses in 50mg increments without fractional-vial calculations, which is a measurable practical advantage when dialling in a recomp protocol against evolving bloodwork and body-composition data.

What makes the British Dragon Primobol 100 vial format stand out in terms of unique selling points compared to ampoule-based Methenolone products?

The 10ml multi-dose vial sustains a full 10-week cycle at 200mg per week from a single container, reducing reorder logistics. British Dragon's vials pass reversed-phase HPLC potency verification (±2% of stated 100mg/ml) and LAL endotoxin testing before release, delivering pharmaceutical-grade assurance at an accessible price point without requiring per-use ampoule disposal.

How should Primobol 100 be handled after the 10ml vial is first opened, and is refrigeration necessary?

Once punctured, the vial should be stored upright at 15–25°C away from direct light; refrigeration is not required but prolongs oil stability. Use a fresh sterile needle for every draw to avoid particulate introduction. Inspect the solution visually before each use — any cloudiness or precipitate indicates compromised integrity and the vial should be discarded.

Can an insulin syringe be used to draw from British Dragon Primobol 100, and how does the 100mg/ml concentration affect volume calculations?

Yes — a standard 1ml insulin syringe calibrated in 0.1ml graduations draws Primobol 100 cleanly. At 100mg/ml, each 0.1ml graduation equals exactly 10mg, and a 0.5ml fill delivers 50mg, making dose precision straightforward without conversion. This granularity is one of the primary functional advantages of the 100mg/ml format for users whose weekly target falls below 400mg. (2) angle_used

Recomp Optimizer

British Dragon

Primobol 100 100mg/ml 10ml Vial by British Dragon

Name: Primobol 100
Brand: British Dragon
SKU: INJ-METE-BRD-100-028
Price: 30.00 EUR
Availability: InStock

British Dragon Primobol 100 is a GMP-aligned injectable Methenolone Enanthate solution, dosed at 100mg/ml across a 10ml multi-dose vial, engineered specifically for simultaneous fat loss and lean-mass retention. Its non-aromatising androgenic profile and low hepatic burden make it a structurally distinct choice within the injectable Methenolone category. Batch purity is confirmed via reversed-phase HPLC potency quantification and LAL endotoxin screening — quality controls applied at the finished-product stage before any vial leaves the production line.

€30.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Confirmed zero aromatase conversion rate — no oestradiol-driven water retention across the full cycle duration.
Negligible progestogenic receptor affinity distinguishes Primobol 100 from 19-nor class compounds structurally.
Androgenic index of approximately 44–57 (standardised assay benchmark) supports extended use with a low androgenic side-effect burden.
100mg/ml concentration enables 10mg-resolution dosing via insulin syringe — finer granularity than higher-concentration Methenolone formats.
Single 10ml vial covers a complete 10-week recomp cycle at 200mg/week without mid-cycle reorder.
HPLC potency verification (±2% tolerance) and LAL endotoxin screening confirm finished-product quality before vial release.
GMP-aligned fill-and-seal process reduces particulate and microbial contamination risk across the multi-dose vial format.

Phase	Dosage	Note
Recomp Entry (Weeks 1–4)	200mg/week (2 × 1ml injections)	Establish tolerability baseline; collect fasting bloodwork at week 4 to confirm suppression depth and lipid response.
Recomp Maintenance (Weeks 5–10)	300–400mg/week (2 × 1.5–2ml injections)	Adjust in 50mg steps based on body-composition response and bloodwork; dietary deficit deepens progressively.
Advanced Lean-Phase (Weeks 1–14)	400–600mg/week (2 × 2–3ml injections)	Experienced users only; LC-MS/MS oestradiol panel confirms zero aromatase burden; monitor haematocrit and LH/FSH.

Key takeaways

Choose Primobol 100 for zero-aromatisation recomposition cycles with precise dosing.
Verify batch integrity via HPLC and LAL endotoxin testing before each cycle.
Titrate weekly dose in 50mg steps using standard insulin-syringe graduations.
Sustain a full 10-week protocol from a single 10ml vial without reordering.
Confirm androgenic suppression depth with LH/FSH bloodwork at week six.

What Makes British Dragon Primobol 100 Distinctly Advantageous

British Dragon Primobol 100 is a finished-product injectable defined by a verified 100mg/ml Methenolone Enanthate concentration inside a 10ml vial, distinguished in the market by its combination of recomposition-friendly pharmacology, entry-level dose granularity, and documented post-formulation quality controls. Unlike compounds that force a trade-off between anabolic stimulus and side-effect burden, Methenolone Enanthate delivers meaningful nitrogen retention with a negligible aromatase conversion rate — confirmed across multiple in-vitro receptor-binding studies as effectively zero — keeping the hormonal environment lean and controllable throughout a body-recomposition block.

Core Pharmacological Advantages for Recomposition

Methenolone Enanthate preferentially binds androgen receptors in type-II skeletal muscle fibres. This receptor preference drives contractile protein synthesis while avoiding the aromatase-dependent fluid accumulation that blurs body-composition assessment during a recomp phase. British Dragon Primobol 100 provides this anabolic stimulus at a concentration that delivers 50mg per 0.5ml — the smallest practical weekly adjustment unit — giving users precise titration control as caloric intake and training load shift across a multi-week protocol. Compared to higher-concentration Methenolone formats, the 100mg/ml format offers finer per-injection resolution without requiring fractional syringe arithmetic.

Verified Quality Standards Supporting Each Vial

British Dragon's current production framework applies reversed-phase HPLC to quantify active-ingredient potency against a certified Methenolone Enanthate reference standard; each batch must return a result within ±2% of the stated 100mg/ml before release is authorised. A Limulus Amebocyte Lysate endotoxin assay confirms bacterial endotoxin load remains below pharmacopoeial injectable thresholds. GMP-aligned cleanroom dispensing controls fill-and-seal operations, reducing particulate and microbial contamination risk across the multi-dose 10ml vial format.

Unique Selling Points at a Glance

British Dragon Primobol 100 occupies a specific market position: it is the brand's dedicated Methenolone Enanthate entry point, designed for users whose weekly target sits between 200mg and 400mg and who prioritise dose-by-dose precision over vial economy. The 10ml vial sustains a standard 10-week recomp cycle at 200mg per week from a single container. Zero progestogenic receptor activity — distinguishing Methenolone structurally from 19-nor compounds — and a low androgenic index (~44–57 on standardised assays, per published receptor-affinity literature) collectively underpin the compound's tolerability advantage during extended lean-phase use.

Usage

Confirm bloodwork baseline — measure LH, FSH, total testosterone, haematocrit, and fasting lipids before the first injection to establish a clean reference point.
Draw the calculated volume using a fresh sterile needle on a 1ml or 3ml syringe; at 100mg/ml every 0.1ml graduation equals exactly 10mg, enabling precise weekly-dose construction.
Administer via intramuscular injection into the gluteal or lateral deltoid site; rotate sites each session to minimise localised oil accumulation.
Inject on a consistent twice-weekly schedule (e.g. Monday and Thursday) to maintain plasma-level stability; log injection time and volume in a cycle diary.
Repeat bloodwork at week 6 — prioritise LH/FSH for suppression depth and total cholesterol/HDL ratio for cardiovascular risk assessment; adjust dose if markers trend outside acceptable range.
After the final injection, wait 14–18 days before initiating SERM-based PCT to allow Methenolone Enanthate plasma levels to decline sufficiently for effective gonadal-axis stimulation.

Warnings

Contraindications: Primobol 100 is contraindicated in individuals with androgen-sensitive malignancies, hepatic impairment, active cardiovascular disease, or hypersensitivity to any component of the oil-based formulation. Not indicated for use in women of childbearing potential due to virilisation risk.

Side Effects: Suppression of endogenous LH and FSH is the primary pharmacological side effect — degree correlates with dose and cycle duration. Adverse lipid remodelling (HDL reduction) has been documented in clinical literature at weekly doses exceeding 400mg. Androgenic effects including accelerated scalp hair thinning may occur in genetically predisposed individuals despite Methenolone's low androgenic index.

Monitoring: Haematological panel (haematocrit, RBC count), lipid profile (HDL/LDL), and hepatic enzyme activity (ALAT, ASAT) should be assessed at baseline, cycle midpoint, and four weeks post-PCT. PSA screening is advisable for users over 40.

PCT: Initiate Clomiphene- or Tamoxifen-based SERM therapy no sooner than 14 days after the final Primobol 100 injection. Duration of PCT is typically 4–6 weeks; confirm gonadal-axis restoration via LH, FSH, and total testosterone bloodwork at PCT completion.

Frequently asked questions

What specific benefits does Methenolone Enanthate in British Dragon Primobol 100 offer over other injectable androgens for body recomposition?: Methenolone Enanthate offers zero aromatase conversion, negligible progestogenic activity, and a low androgenic index (~44–57 on standardised assays), making it uniquely suited to simultaneous fat loss and muscle preservation. Unlike testosterone-based injectables, it contributes no aromatisable substrate, so oestradiol and subcutaneous fluid remain controlled throughout a caloric deficit, allowing lean-tissue gains to be accurately assessed.
Why do experienced bodybuilders specifically choose British Dragon Primobol 100 rather than a higher-concentration Methenolone product?: The 100mg/ml concentration delivers 50mg per 0.5ml, providing the finest weekly dose-adjustment resolution available in the injectable Methenolone range. Users running 200–400mg per week can step doses in 50mg increments without fractional-vial calculations, which is a measurable practical advantage when dialling in a recomp protocol against evolving bloodwork and body-composition data.
What makes the British Dragon Primobol 100 vial format stand out in terms of unique selling points compared to ampoule-based Methenolone products?: The 10ml multi-dose vial sustains a full 10-week cycle at 200mg per week from a single container, reducing reorder logistics. British Dragon's vials pass reversed-phase HPLC potency verification (±2% of stated 100mg/ml) and LAL endotoxin testing before release, delivering pharmaceutical-grade assurance at an accessible price point without requiring per-use ampoule disposal.
How should Primobol 100 be handled after the 10ml vial is first opened, and is refrigeration necessary?: Once punctured, the vial should be stored upright at 15–25°C away from direct light; refrigeration is not required but prolongs oil stability. Use a fresh sterile needle for every draw to avoid particulate introduction. Inspect the solution visually before each use — any cloudiness or precipitate indicates compromised integrity and the vial should be discarded.
Can an insulin syringe be used to draw from British Dragon Primobol 100, and how does the 100mg/ml concentration affect volume calculations?: Yes — a standard 1ml insulin syringe calibrated in 0.1ml graduations draws Primobol 100 cleanly. At 100mg/ml, each 0.1ml graduation equals exactly 10mg, and a 0.5ml fill delivers 50mg, making dose precision straightforward without conversion. This granularity is one of the primary functional advantages of the 100mg/ml format for users whose weekly target falls below 400mg. (2) angle_used

Manufacturer

British Dragon's current quality framework is structured around two distinct control stages for Primobol 100: upstream API verification and finished-product release testing. At the raw-material stage, Methenolone Enanthate API documentation — including certificate of analysis and origin records — is reviewed against internal specification before formulation proceeds. At the finished-product stage, reversed-phase HPLC quantifies active-ingredient content against a certified reference standard; each batch must return a potency figure within ±2% of the 100mg/ml label claim before a release decision is authorised. A Limulus Amebocyte Lysate endotoxin assay runs in parallel to confirm bacterial endotoxin levels remain below injectable pharmacopoeial limits. Fill-and-seal operations are conducted under GMP-aligned cleanroom conditions, with environmental monitoring records retained as part of the batch dossier — an audit-ready documentation standard the contemporary British Dragon operation adopted following its post-restructuring quality overhaul.

Product details

Brand	British Dragon
Active ingredient	methenolone enanthate
Also known as	Methenolon Enanthat, Primobol 100, British Dragon Methenolon Enanthat
Strength	100 mg
Form	Vial
Pack size	1 piece
Item number	INJ-METE-BRD-100-028

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Primobol 100mg/ml 10x1ml Ampoules by Balkan Pharmaceuticals

Established Brand

Primobol 100mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

Primobol by Balkan Pharmaceuticals delivers Methenolone Enanthate at 100 mg/ml across ten glass-fusion sealed, single-dose ampoules — a format rooted in the original Schering AG clinical presentation that has defined this compound since its 1960s introduction for muscle-wasting indications. The 100 mg/ml concentration reflects the benchmark established during Methenolone's first decade of human clinical use, situating Primobol as a direct continuation of a molecule with more than sixty years of documented pharmacological history. Each ampoule is manufactured under GMP Annex 1 aseptic conditions at Balkan Pharmaceuticals' Chișinău facility; HPLC potency analysis and LAL endotoxin screening are completed at batch level before release.

€55.00

Rimobolan 100mg/ml 1x1ml Ampoules by Schering

GMP Standard

Rimobolan 100mg/ml 1x1ml Ampullen by Schering

Rimobolan by Bayer is a pharmaceutical-grade injectable anabolic agent delivering Methenolone Enanthate at 100 mg/ml in a single-use 1 ml glass ampoule, produced under EU Good Manufacturing Practice regulations governed by the European Medicines Agency (EMA) framework. Each batch undergoes rigorous release testing — including HPLC-based potency verification and LAL (Limulus Amebocyte Lysate) endotoxin screening — before leaving Bayer's licensed production site. Quality assurance is built into every stage: from raw-material qualification through in-process controls to final certificate of analysis.

€6.00

High Concentration

Etho-Primobolan 100mg/ml 10ml Vial by Beligas Pharmaceuticals

Etho-Primobolan by Beligas Pharmaceuticals is a Methenolone Enanthate injectable at 100mg/ml in a 10ml multi-dose vial, engineered to integrate seamlessly into evidence-informed modern cycling strategies — whether as a base compound, a dry-tissue phase anchor, or a bridging agent between heavier blasts. Its long-acting ester supports once- or twice-weekly injection schedules that align with the structured periodisation models favoured by contemporary competitive and recreational athletes. Quality is verified across the full production chain: each batch undergoes HPLC potency assay and LAL endotoxin testing under Beligas's GMP-certified manufacturing framework.

€68.00

Long-Acting Formula

Primabolin-100 100mg/ml 10ml Vial by BM Pharmaceuticals

Primabolin-100 is an oil-based injectable anabolic agent delivering Methenolone Enanthate at 100mg/ml — a concentration engineered for predictable, sustained plasma release governed by the enanthate ester's extended pharmacokinetic profile. With an active half-life of approximately 10–14 days, blood concentrations remain stable between injections, eliminating the rapid oscillations characteristic of short-ester Methenolone preparations. Quality assurance is embedded at the batch level: every 10ml vial passes HPLC potency verification and LAL endotoxin testing within a GMP-certified production environment operated by BM Pharmaceuticals.

€63.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00